Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07201194

HOL-AKU: Holistic Acupuncture for Patients With Chemotherapy Induced Nausea

Led by Vejle Hospital · Updated on 2026-05-28

90

Participants Needed

1

Research Sites

39 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying whether adding acupuncture to standard anti-nausea medicine can better reduce nausea caused by chemotherapy compared to using anti-nausea medicine alone. The study involves 90 patients who experience chemotherapy-induced nausea and aims to assess the level of nausea and other cancer-related symptoms at different times during the study. Participants are randomly assigned to one of two groups: one group receives holistic acupuncture and acupressure along with their anti-nausea medication, while the other group receives only the standard anti-nausea treatment. The acupuncture involves a personalized consultation following Traditional Chinese Medicine principles, using up to 10 needles inserted for 25 minutes during chemotherapy visits. Both groups continue to receive standard chemotherapy and supportive care. During the study, patients will report their nausea levels using a specific questionnaire at baseline, then again at 8 and 22 days after joining. Researchers will monitor symptoms closely and manage side effects while tracking the patients' overall health and treatment adherence. This process helps measure the impact of adding acupuncture on nausea and symptom intensity over the course of chemotherapy.

CONDITIONS

Brief Title

Holistic Acupuncture for Patients With Chemotherapy Induced Nausea

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years of age or older
  • Undergoing chemotherapy and experiencing nausea despite following prescribed antiemetic medication
  • Understands and speaks Danish
  • Provided written and oral informed consent
  • Scheduled for chemotherapy treatment every 14 days
  • At least two chemotherapy cycles planned at the time of inclusion
Not Eligible

You will not qualify if you...

  • Presence of brain metastases
  • Performance status greater than 2

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Treatment

Duration - At least 2 chemotherapy cycles (approximately 4 weeks or more)

Participants receive holistic acupuncture and acupressure as a supplement to their standard chemotherapy care. The acupuncture involves a one-time individualized consultation with an oncologist trained in acupuncture, during which up to 10 needles are applied and remain in place for 25 minutes. Treatment is aligned with participants' chemotherapy schedule every 14 days.

1 acupuncture consultation per chemotherapy cycle (every 14 days)

Trial Site Locations

Total: 1 location

1

Department of Oncology, Vejle Hospital

Vejle, Denmark, 7100

Actively Recruiting

Loading map...

Research Team

M

Mette Stie, PhD

N

Nanna Nordestgaard Madsen, MScN

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

Investigating The Role of Key Non-coding RNA(s) in Breast Ca...

Breast Cancer

Actively Recruiting

1 location

A Phase 1/2a Study of the Safety, Tolerability, and Prelimin...

Castration-Resistant Prostate Cancer (CRPC)

Actively Recruiting

4 locations

177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With...

Prostate Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here